[PDF][PDF] Fluoxetine use is associated with improved survival of patients with COVID-19 pneumonia: A retrospective case-control study.
ZK Németh, A Szûcs, J Vitrai, D Juhász… - Clinical Neuroscience …, 2021 - real-j.mtak.hu
Background and purpose–We aimed to investigate the association between fluoxetine use
and the survival of hospitalised coronavirus disease (COVID-19) pneumonia patients …
and the survival of hospitalised coronavirus disease (COVID-19) pneumonia patients …
Do the selective serotonin reuptake inhibitor antidepressants fluoxetine and fluvoxamine reduce mortality among patients with COVID-19?
N Hoertel - JAMA network open, 2021 - jamanetwork.com
In a large, multicenter, retrospective cohort study of 83 584 patients with laboratory-
confirmed COVID-19 who had an emergency department or urgent care visit or were …
confirmed COVID-19 who had an emergency department or urgent care visit or were …
The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
Abstract Background and Aim Due to the high social and economic burden and also
mortality and morbidity caused by coronavirus disease 2019 (COVID‐19) in the past few …
mortality and morbidity caused by coronavirus disease 2019 (COVID‐19) in the past few …
Antidepressants for COVID-19: A systematic review
Objective To systematically examine the efficacy and safety of antidepressants for the
treatment of coronavirus disease 2019 (COVID-19). Methods A systematic search was …
treatment of coronavirus disease 2019 (COVID-19). Methods A systematic search was …
Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants
Importance Antidepressant use may be associated with reduced levels of several
proinflammatory cytokines suggested to be involved with the development of severe COVID …
proinflammatory cytokines suggested to be involved with the development of severe COVID …
[HTML][HTML] Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis
Background The efficacy of selective serotonin reuptake inhibitors (SSRIs) in the treatment
of acute COVID-19 is still under investigation, with conflicting results reported from …
of acute COVID-19 is still under investigation, with conflicting results reported from …
The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis
H Nakhaee, M Zangiabadian, R Bayati, M Rahmanian… - PloS one, 2022 - journals.plos.org
Introduction Clinical Depression and the subsequent low immunity is a comorbidity that can
act as a risk factor for the severity of COVID-19 cases. Antidepressants such as Selective …
act as a risk factor for the severity of COVID-19 cases. Antidepressants such as Selective …
Relationship between antidepressants and severity of SARS-CoV-2 Omicron infection: a retrospective cohort study using real-world data
H Wang, Y Wei, CT Hung, X Jiang, C Li… - The Lancet Regional …, 2023 - thelancet.com
Background Few studies have used real-world data to evaluate the impact of antidepressant
use on the risk of developing severe outcomes after SARS-CoV-2 Omicron infection …
use on the risk of developing severe outcomes after SARS-CoV-2 Omicron infection …
Antidepressant use and its association with 28-day mortality in inpatients with SARS-CoV-2: support for the FIASMA model against COVID-19
To reduce Coronavirus Disease 2019 (COVID-19)-related mortality and morbidity, widely
available oral COVID-19 treatments are urgently needed. Certain antidepressants, such as …
available oral COVID-19 treatments are urgently needed. Certain antidepressants, such as …
Association between SSRI antidepressant use and reduced risk of intubation or death in hospitalized patients with coronavirus disease 2019: a multicenter …
Objective To examine the association between antidepressant use and the risk of intubation
or death in hospitalized patients with COVID-19. Design Multicenter observational …
or death in hospitalized patients with COVID-19. Design Multicenter observational …